We injected neonatal rats with nerve growth factor, the antiserum to nerve growth factor, or placebo for the first 10 days of life. Our goal was to determine the relation between sympathetic innervation of the developing heart, the electrocardiographic expression of cardiac rhythm, and the response of the heart to a-adrenergic stimulation with phenylephrine. We were especially interested in the latter area because of the prior demonstration in isolated cell systems of sympathetic neural modulation of a 41-kDa GTP regulatory protein and c-adrenergic responsiveness. Tento 11-day-old rats treated with nerve growth factor had more complete sympathetic innvervation, faster heart rates, and higher levels of the 41-kDa protein than the placebo group. Electrophysiological studies were performed on isolated ventricular septa superfused with Tyrode's solution at 37.0°-37.5°C. The electrophysiological response of septa to 10`and 10-8 M phenylephrine from the 10-11-day-old nerve growth factor group was comparable with that of 3-week-old control animals. In contrast, 10-11-day-old antiserumtreated rats had an abnormal innervation pattern, lower levels of the 41-kDa protein, and a more immature electrophysiological response to a-adrenergic stimulation than the placebo group. In addition, antiserum-treated rats had an abnormally prolonged electrocardiographic QT interval. Our results demonstrate for the first time in intact animals a direct link between sympathetic innervation and a!-adrenergic receptor-effector coupling as well as the dependence on innervation of the modulation of impulse initiation by a!-agonists. This sequence of developmental events may be important not only in the regulation of normal cardiac rhythm but also in the expression of certain pathological entities such as the congenital long QT syndrome and the sudden infant death syndrome. (Circulation Research 1990;66:427-437) Sympathetic neural growth and innervation are essential to the maturation of cardiac aadrenergic receptor-effector coupling. For example, in neonatal and adult canine Purkinje fibers1'2 and in neonatal and adult rat ventricle, which beats spontaneously as a result of Purkinje fiber automaticity,3 the chronotropic response to a1adrenergic stimulation changes from an increase in automaticity in the immature noninnervated state to a decrease in automaticity after maturation and sym-From the pathetic innervation. Sympathetic innervation induces the functional expression of a pertussis toxin-sensitive GTP regulatory protein in neonatal rat ventricular myocytes in tissue culture4 that links the a1adrenergic receptor to inhibition of automaticity.4,5
We injected neonatal rats with nerve growth factor, the antiserum to nerve growth factor, or placebo for the first 10 days of life. Our goal was to determine the relation between sympathetic innervation of the developing heart, the electrocardiographic expression of cardiac rhythm, and the response of the heart to a-adrenergic stimulation with phenylephrine. We were especially interested in the latter area because of the prior demonstration in isolated cell systems of sympathetic neural modulation of a 41-kDa GTP regulatory protein and c-adrenergic responsiveness. Tento 11-day-old rats treated with nerve growth factor had more complete sympathetic innvervation, faster heart rates, and higher levels of the 41-kDa protein than the placebo group. Electrophysiological studies were performed on isolated ventricular septa superfused with Tyrode's solution at 37.0°-37.5°C. The electrophysiological response of septa to 10`and 10-8 M phenylephrine from the 10-11-day-old nerve growth factor group was comparable with that of 3-week-old control animals. In contrast, 10-11-day-old antiserumtreated rats had an abnormal innervation pattern, lower levels of the 41-kDa protein, and a more immature electrophysiological response to a-adrenergic stimulation than the placebo group. In addition, antiserum-treated rats had an abnormally prolonged electrocardiographic QT interval. Our results demonstrate for the first time in intact animals a direct link between sympathetic innervation and a!-adrenergic receptor-effector coupling as well as the dependence on innervation of the modulation of impulse initiation by a!-agonists. This sequence of developmental events may be important not only in the regulation of normal cardiac rhythm but also in the expression of certain pathological entities such as the congenital long QT syndrome and the sudden infant death syndrome. (Circulation Research 1990; 66:427-437) Sympathetic neural growth and innervation are essential to the maturation of cardiac aadrenergic receptor-effector coupling. For example, in neonatal and adult canine Purkinje fibers1'2 and in neonatal and adult rat ventricle, which beats spontaneously as a result of Purkinje fiber automaticity,3 the chronotropic response to a1adrenergic stimulation changes from an increase in automaticity in the immature noninnervated state to a decrease in automaticity after maturation and sym-pathetic innervation. Sympathetic innervation induces the functional expression of a pertussis toxin-sensitive GTP regulatory protein in neonatal rat ventricular myocytes in tissue culture4 that links the a1adrenergic receptor to inhibition of automaticity. 4, 5 We believed it important to determine whether altering sympathetic neural development in vivo would modulate a-adrenergic responsiveness in a manner predicted by earlier in vitro studies. Therefore, we enhanced or interrupted sympathetic nerve growth in newborn rats and analyzed the effects of these interventions on the ventricular chronotropic response to a-adrenergic stimulation, on the pertussis toxin-sensitive GTP regulatory protein, and on the anatomic distribution of sympathetic neural tissue (measured immunohistochemically). In addition, we examined the effects of these interventions on the electrocardiograms of the newborn rats to identify changes in rate, rhythm, and repolarization. We shall demonstrate that alterations in sympathetic nerve growth not only modify automaticity and GTP regu-latory protein development, but they alter the electrocardiographic QT interval as well. The latter change is of interest because experimental and clinical studies have suggested a pathogenetic role of abnormal sympathetic neural development or function in some instances of the sudden infant death syndrome6,7 and in the congenital long QT syndrome.8
Materials and Methods
We studied littermate Wistar rats born in our animal care facility. In preliminary experiments, the ventricular chronotropic response to a,-adrenergic stimulation was studied in control rats at 5-6, 10-11, and 21 days of age. Based on these results (see below), we performed the remainder of the study on days 10-11 of life.
We randomly divided each litter into three groups on the day of birth. Animals were weighed on day 0, at 10-11 days, and at 3 weeks. Each rat was injected subcutaneously on days 0-9 of life with one of the following solutions: 1) 1.0 ,Lgg/day nerve growth factor (NGF) until day 5, then 1.5 ,ug/day, 2) 10 ,ld/day NGF antiserum until day 5, then 15 gal/day, or 3) placebo (saline). Solutions were administered in a final volume of 100 gl. NGF and NGF antiserum were purchased from Collaborative Research, Bedford, Massachusetts. The initial dose of NGF antiserum was that used by Levi Montalcini and Booker.9 The initial dose of NGF is lower than that described by Levi Montalcini and Booker10 and by Angeletti et al. 11 The reason for using the lower dose was the greater biological activity of the Collaborative Research preparations as compared with that used by Levi Montalcini and Booker10 and by Angeletti et al.1' The reason for increasing the dose on day 5 of life was to maintain the amount of antiserum or NGF given in light of the weight gain of the animals.
We recorded the ECGs of animals in the three treatment groups on days 0-1 and 10 and (in a subset) at 3 weeks of age. For this procedure, rats were lightly restrained; two thin leads were taped to the right shoulder and the left flank, and a bipolar recording was obtained to calculate standard electrocardiographic intervals (RR, PR, QRS, and QT). We then tested for a linear correlation between QT intervals and RR intervals in the rat ECG. The formula derived was QT=59.6+0.15RR (r, 0.52; slope, 0.15; p<0.01). Based on this correlation, we used Bazett's formula12 to rate-correct the QT interval. Because questions have been raised about the validity of the Bazett formula, especially at rapid heart rates,13 we present both absolute and ratecorrected measurements of QT.
On the day of the study, animals were decapitated after CO2 narcosis or anesthetized with 30 mg/kg i.p. pentobarbital. The hearts were removed through a midsternal thoracotomy, and the atria were trimmed away. In the 10-11-day-old rats, we then performed studies aimed at determining the extent of sympathetic innervation, the effects of a,-adrenergic stimulation on ventricular automaticity, and the levels of the pertussis toxin-sensitive family of GTP regulatory proteins. Electrophysiological studies were performed on ventricular septal preparations as previously described.14 These preparations developed regular rhythmic activity in contrast to free wall preparations, in which rhythms tend to be irregular. For studies of GTP regulatory proteins and tissue catecholamine levels, we used the ventricular free walls of the same preparations in which septal electrophysiology was studied, as well as septal preparations. Hearts used for tyrosine hydroxylase staining were not studied electrophysiologically.
Estimation of Sympathetic Innervation
We used an antibody to tyrosine hydroxylase as an immunohistochemical marker for sympathetic neurons. After cardiectomy, the interventricular septum of each heart was rapidly dissected, washed in chilled Tyrode's solution, and placed in Zamboni's fixative for 1-2 hours. The tissue was then washed in 15% sucrose in 0.1 M phosphate buffer and frozen in a cryomicrotome. Forty-micron-thick sections were cut and collected in 0.1 M phosphate buffer. The freefloating thick sections were then incubated in antibody to tyrosine hydroxylase (Eugene Technical International, Allendale, New Jersey) at a concentration of 1:1,500 over 40-48 hours at 40 C. Incubations in second antibody and development using standard immunoperoxidase methods preceded mounting on glass slides.
We determined tissue norepinephrine and dopamine levels as a biochemical marker of cardiac sympathetic innervation. Right and left ventricles of hearts in each treatment group were flash-frozen and stored at -70°C until the day of the assay. For each treatment group, representative samples were then pooled and assayed for norepinephrine and dopamine using the Cat-a-kit.2 A modification of the method of Lowry et al'5 was used to measure the total protein. Results are expressed as nanograms per milligram protein.
Studies of VentricularAutomaticity
Interventricular septa were dissected and placed in a tissue bath perfused at 12 ml/min with Tyrode's solution containing (mM/l) NaCl 131, NaHCO3 18, CaCl2 2.7, MgCl2 0.5, NaH2P04 1.8, KCl 2.7, and dextrose 5.5 (pH 7. 35-7.4) . The solution was gassed with 95% 02-5% CO2 and warmed to 37.0°-37.5°C. The automatic rate of the preparations was monitored with Teflon-coated bipolar silver-wire electrodes, which were connected through an amplifier to a stripchart recorder.314 We studied only those preparations in which spontaneous rhythms remained stable (±5%) for an equilibration period of 20 minutes and for a subsequent control period of 20 minutes. After the control period, the experiment was begun. In some experiments in each treatment group, we first determined the responses of the preparations to 10-7 M tyramine and then allowed a washout of 30 minutes. All septa were then exposed to 10-9 and 10-8 M phenylephrine (Sigma Chemical, St. Louis, Missouri) for 10 minutes at each dose. A steady state was usually attained within 5-6 minutes.3 After exposure to the highest agonist concentration, a washout in Tyrode's solution was performed.
Studies of the GTP Regulatory Proteins
The 41-kDa family of GTP regulatory proteins is a substrate for ADP-ribosylation by pertussis toxin. Assays of pertussis toxin-sensitive GTP regulatory proteins measure the incorporation of [32P]ADPribose from [32P]nicotinamide adenine dinucleotide (NAD) into an appropriate molecular weight membrane protein as previously described. 5 We activated pertussis toxin (List, Campbell, California) by incubation with 10 mM dithiothreitol for 10 minutes at 300 C. Ventricular membranes (10 ,ug) were incubated in 65 ,gl of a 50 mM potassium phosphate buffer (pH 7.5) containing 10 units aprotinin, 13 mM thymidine, 3.2 mM ADP-ribose, 13 mM arginine, 0.2 mM GTP, and 10 ,uM [32P]NAD Ci/mmol) in the presence or absence of 2 mg activated pertussis toxin for 20 minutes at 300 C. The ADP-ribosylation reaction was performed in the presence and absence of 0.1% Lubrol's detergent. The reaction was stopped by adding 1 ml ice-cold 7% trichloroacetic acid (TCA) and centrifuging at 12,000g. The pellet was washed by resuspension in 1% TCA and recentrifugation at 12,000g and then solubilized with sodium dodecyl sulfate (SDS) sample buffer. Electrophoresis was performed on vertical slab gels (resolving gel 10%, stacking gel 5% acrylamide) at 300 V for 3 hours; the gels were stained with Coomassie blue and autoradiographed by exposure to Kodak XRP-5 film (Eastman Kodak, Rochester, New York). The specific protein band on the polyacrylamide gel that corresponded with the labeled band on the autoradiogram was excised and counted by liquid scintillation spectroscopy. The concentration of pertussis toxin-sensitive G protein was determined by relating the number of counts in this band to the specific activity of the [32P]NAD and the protein concentration employed. Results are reported as ADP-ribosylatable G protein measured in the absence of detergent to maintain consistency with previous G protein measurements in rat ventricular cardiac tissue.4 Detergent markedly increased the total amount of pertussis toxin-sensitive G protein measured but did not alter the relation of the pertussis toxin-sensitive G protein among experimental conditions. Studies of a-Adrenergic Receptors a-Receptors were characterized by use of 2- Values for tissue norepinephrine, dopamine, and GTP regulatory protein levels were compared with one-way ANOVA. All differences were considered significant at p<O0.05.
Results
We determined body weight at 1 day and at 10-11 days in 42 animals and at 3 weeks in nine animals. At 1 day, body weight was similar among groups (6.6+0.2 g). At 10-11 days, NGF-treated rats were significantly smaller (18.5 +2.8 g) than antibodytreated (23+2.0) and placebo-treated (22+3.0 g) rats, as previously described.9-1" At 3 weeks (11 days after all treatment had been stopped), no differences in body weight were present (56± 4.0 g). Heart weight at days 10-11 was comparable in all three treatment groups (antiserum, 137+6.2 mg; placebo, 133+6.4 mg; NGF, 125-+-7.0 mg; p>0.05). 
Values are mean±SEM. Ab, nerve growth factor antiserum-treated group; Plac, placebo-treated group; NGF, nerve growth factortreated group. n=25 to 26 at 0-1 day; n=18 to 26 at 10 days; and n=5 to 7 at 3 weeks. *p<0.05 vs. its control at 0-1 day. tp<0.05 vs. NGF.
:p<O.OS vs. Ab.
§p<0.05 vs. Plac. Table 1 summarizes the effects of the different treatments on the ECG, and Figure 1 shows examples of the electrocardiograms obtained. Good definition of P, QRS, and T waves and of the QT interval was present in most instances; in less than 10%, measurement of the QT interval was not technically possible. The average heart rate on days 1-2 (Table  1 ) was in the range reported by others2021 and was similar among groups. In contrast, on the tenth day, rats that had received NGF treatment had a significantly faster heart rate (Table 1, Figure 2 ) than the other groups. The PR interval was similar among groups and shortened between days 1-2 and 10; no further decrease was observed at 3 weeks. No differences in the QT interval were present among groups on days 1-2, but on the tenth day, the NGF antiserumtreated rats had a significantly longer QT than the other two groups (Table 1, Figure 2 ). At 3 weeks, all groups again had a similar QT interval (Table 1, Figure   2 ), irrespective of the treatment received on days 0-9.
ECG Characteristics of the Treatment Groups

Studies of Ventricular Innervation
Ventricular norepinephrine and dopamine levels were measured in five sets of pooled ventricles from each treatment group on days [10] [11] (Table 2 ). In NGF antiserum-treated ventricles, norepinephrine was 65% of that in the placebo group (p<0.05); conversely, in NGF-treated ventricles, norepinephrine levels were 34% greater than placebo (p<0.05). The highest dopamine levels (nearly four times greater than placebo) were found in the NGF antiserum-treated ventricles (p <0.05). Dopamine levels in NGF-treated rats were only 43% of those from placebo-treated animals (p<0.05).
We used immunocytochemical localization of tyrosine hydroxylase to determine distribution and relative amounts of sympathetic neural tissue in the interventricular septa from the three neonatal rat groups, as compared with adult controls (Figure 3) . Septa from the placebo-treated 10-day-old animals resembled those from adult rats in that there were few tyrosine hydroxylase-positive neurons (NGF)-treated rats was higher than in the other two groups (p<0.05), and the NGF antiserum-treated (Ab) rats had a significantly longer QT, than the NGF-treated and placebotreated (P1) groups. On days 20-21 (approximately 11 days after cessation of treatment), heart rate was still faster in the NGF-treated group, but the QT, intervals no longer differed.
(For n, see Table 1 . Note that there are only five to seven rats per group at 3 weeks.) *p<0.05 vs. other two groups at the same age.
the endocardium. In contrast, septa from both the NGF-treated and NGF antiserum-treated animals showed considerably more tyrosine hydroxylase. The NGF-treated septa demonstrated numerous welldefined sympathetic neurons and small nerves in the endocardium and, in many areas, the subjacent myocardium. The antiserum-treated septa contained large patchy endocardial and myocardial regions of tyrosine hydroxylase-stained tissue that did not resemble the neural tissue seen in the other groups. Characterized by mottled staining of structures with hazy margins, these poorly defined collections of tyrosine hydroxylase positivity precluded indentification of individual neurons. We used tyramine superfusion to test the physiological intactness of the sympathetic nerves. Twentythree preparations representing the three treatment groups of 10-11-day-old rats were superfused with 10`M tyramine, and the steady-state rate was determined. A significant increase in automaticity occurred in all groups (Figure 4 ). However, the changes in automatic rate induced in each setting differed significantly; the positive chronotropic response observed in septa from NGF-treated rats was the greatest and that in the NGF antiserumtreated septa was the smallest (p<0.05).
Chronotropic Responses of Ventricular Septa to Phenylephrine
The initial spontaneous rates of all ventricular septal preparations studied at 1-2, 10-11, and 21 days were similar for all three interventions within any age range (see legends of Figures 5-7) . As additional controls, we studied the developmental changes in the chronotropic effects of phenylephrine in 10 septa from untreated 5-6-day-old rats, nine septa from untreated 3-week-old rats, and five septa from untreated 10-11-day-old rats. In this study, as previously,1-5 we segregated the hearts based on whether phenylephrine induced a positive or negative chronotropic response. In 5-6-day-old rats, we found a predominant increase in automaticity (8 of 10 rats); in the 3-week-old rats there was a predominant decrease (8 of 9 rats) ( Figure 5 ). Three of the ventricles from 10-day-old rats showed decreased automaticity, and two showed increased automaticity. We also determined the 41-kDa pertussis toxin substrate in the 10-day-old rats: this was 279 fmol/mg in the three pooled ventricles showing decreased automaticity and 235 fmol/mg in the two pooled ventricles showing increased automaticity. Figure 6 illustrates the effects of phenylephrine on the automaticity of septa from 10-11-day-old rats randomly assigned to treatment with NGF, placebo, or NGF antiserum. The frequency of a positive chronotropic response to phenylephrine varied significantly (X2 test,p<0.01): 77% (10/13) of the NGF antibody-treated group, 50% (8/16) of the placebotreated group, and 15% (2/13) of the NGF-treated group. These findings are summarized in Figure 7 , in which the normal developmental sequence in fractional positive or negative chronotropic responses to a,-adrenergic stimulation is compared with that observed in our treatment groups. It is evident that the response of 10-11-day-old septa treated with NGF antiserum differed from that of the placebotreated group and was akin to that of more immature and untreated neonatal ventricles (5-6 days old). In contrast, the response of septa from NGFtreated rats was similar to that of more mature ventricles (3 weeks old).
a-Adrenergic Receptors and GTP Regulatory Proteins
The a,-adrenergic receptors were studied in membranes from three sets of pooled ventricular septa and free walls. Each set consisted of six to eight ventricles. No differences were seen among the three groups; that is, for control, NGF, and antibody groups, respectively, the Kd values were 46.6+5.2, 45.1±+10.0, and 45.8±2.9 pM, and the Bm values were 155±14, 175±33, and 142+5 fmol/mg. Hence, Control rate (C, normalized to zero) was similar in the two groups: 88±20 beats/min in septa from ten 5-6-day-old rats and 87±16 beats/min in septa from nine 3-week-old rats. In this and subsequent figures, the hearts were segregated based on their response to Phe. In the first group, there was a prevalent positive chronotropic response, whereas in septa from 3-week-old rats, the response was mainly negative chronotropy. *p <0.05 vs. control. n, number of preparations in each group. Phe (M) FIGURE 6. Graphs showing chronotropic response to phenylephrine (Phe) in septa from 10-11-day-old rats treated with nerve growth factor antiserum (Ab), placebo (Plac), or nerve growth factor (NGF). Control rate (C, normalized to zero) was not significantly different in the three groups: Ab, 91±13 beats/min; Plac, 80±9 beats/min; NGF, 102±13 beats/min. The majority of septa from Ab-treated rats increased in rate with ca-adrenergic stimulation (10 of 13 rats), while the majority ofsepta from NGF-treated rats decreased in rate (11 of 13 rats) (p<0.05). The magnitude of the chronotropic responses in either direction was not different among groups.
PLAC
*p<0.05 vs. control. n, number ofpreparations in each group. studies, indicating that sympathetic innervation induces the functional expression of a pertussis toxin-sensitive G protein,4 inhibition of innervation with NGF antiserum was associated with a diminished level of the pertussis toxin-sensitive GTP regulatory protein (112+19 fmol/mg, 87% of the placebo value of 128+24 fmol/mg,p<0.05), whereas acceleration of innervation with NGF was associated with increased levels of the pertussis toxin-sensitive GTP regulatory protein (157+27 fmol/mg, 23% greater than the placebo value, p<O.05). Although values for the protein here are lower than in our preliminary experiments (above), these were different assays, and it is the differences among values in the subgroups of rats that is of importance. Moreover, in any given litter and for the groups as a whole, the levels of regulatory protein were highest in the NGF group and lowest in the antiserum group. This difference in the level of pertussis toxin-sensitive GTP regulatory protein among the treatment groups is illustrated in Figure 8 , which presents a sample autoradiograph of the SDSpolyacrylamide gel electrophoresis separation of toxin-labeled membrane proteins. The amount of pertussis toxin-dependent 32p incorporation into a similar molecular weight band here is highest in the NGF-treated ventricles and lowest in NGF antiserum-treated ventricles.
Discussion
Maturation of Innervation
In the normally developing rat, complete maturation of the sympathetic nervous system takes place . The chronotropic response is expressed as 'fractional response, " that is, the percent ofpreparations at each age or in each treatment group showing either an increase or a decrease in rate. Treatment with nerve growth factor antiserum (Ab) rendered the chronotropic response to phenylephrine of 10-11-day-old septa more like that of septa from less mature hearts; conversely, septa from nerve growth factor (NGF)treated rats responded like preparations from more mature animals. (First and fifth bars in the upperpanel are from data initially presented in Reference 3).
PL Ab NGF 41-FIGURE 8. Representative autoradiograms showing the relative amount ofpertussis toxin-sensitive substrate in ventricles from the three 10-11-day-old treatment groups. The pertussis toxin substrate was greatest in ventricles from nerve growth factor (NGF)-treated rats and lowest in ventriclesfrom the nerve growth factor antiserum (Ab)-treated group. PL, placebo.
after birth. [22] [23] [24] We used NGF and its antiserum to modify the time course of maturation and tested their efficacy by tyrosine hydroxylase staining, measurement of ventricular norepinephrine and dopamine concentrations, and determination of the automatic response to tyramine. The response to tyramine and the measurement of tissue norepinephrine levels gave results typical of the interventions performed; that is, animals that received NGF showed evidence of greater catecholamine release on tyramine superfusion, whereas the antiserum-treated animals showed a minimal response. Tissue norepinephrine levels (reflecting the presence of sympathetic terminals) were greatest in the NGF-treated animals and least in the antiserum-treated group. Anatomically, we found a considerable increase in the numbers of sympathetic nerve fibers in the hearts of neonatal rats treated with NGF as compared with the placebo-treated animals and adult controls. Although the antiserumtreated group showed abundant tyrosine hydroxylase-sensitive tissue, the poor staining definition of neural elements suggests that the peripheral sympathetic nervous system was disrupted. Other investigators have used biochemical assays to document a decrease in tyrosine hydroxylase activity in anti-NGF-treated sympathetic ganglia and in presynaptic neurons.11,25 However, to our knowledge no one has analyzed the tyrosine hydroxylase content in the peripheral neurons within the end organ or target tissue. Previous investigators,26 employing a histochemical fluorescence method, which visualizes norepinephrine, noted an abnormal and irregular staining pattern of neural tissue in the mouse right atrium 3 days after a single dose of NGF antiserum; however, the fluorescence diminished rapidly thereafter. This is entirely consistent with our study, in which 10 consecutive days of antibody administration was accompanied by an abnormal pattern of tyrosine hydroxylase staining.
The occurrence of abnormal neuronal maturation in the antiserum-treated rats is suggested by tyrosine hydroxylase staining and low tissue norepinephrine levels as well as by the fact that the norepinephrine precursor, dopamine, was highest in the antiserum group (and lowest in the NGF group). It is likely that abnormal nerves in the antiserum group produced, mainly, a precursor of norepinephrine. Recent studies in fetal lambs have documented a variable pattern of dopamine content in end organs of animals treated with NGF antiserum.27 As in our study, these investigators found a marked decrease in norepinephrine, and in many organs, there was a substantial increase in dopamine content. These results indicate that antiserum to NGF interrupts the catecholamine synthesis pathway between dopamine and norepinephrine or that it destroys a negative feedback inhibition mechanism28 and, thus, enables an up-regulation in synthesis of tyrosine hydroxylase and dopamine.
Maturation of the Determinants of the a,-Adrenergic
Chronotropic Response
Phenylephrine was chosen as the agonist because of its relative specificity for a-receptors and because it is not subject to neuronal reuptake as is the natural neurotransmitter, norepinephrine. 29 The ventricular chronotropic response to a1-adrenergic stimulation differed in the three groups in a way that mimicked the normal developmental sequence ( Figure 6 ): septa from NGF antiserum-treated rats usually had a positive chronotropic response to phenylephrine, and septa from NGF-treated rats tended to have a negative chronotropic response. The lack of any difference in a1-adrenergic receptor number and affinity among the three groups of rats suggests that the focus of the developmental change in receptoreffector coupling is distal to the receptor itself. In contrast, the development of a negative chronotropic response to phenylephrine clearly was correlated with the expression of higher levels of the pertussis toxin-sensitive GTP regulatory protein. This is consistent with our data in vitro4 and marks the first confirmation of the association between sympathetic innervation and the development of the 41-kDa pertussis toxin substrate in vivo. Although sympathetic nerve fibers also contain G proteins and are present in variable amounts in ventricular tissue from the three treatment groups, it has been demonstrated that the G protein present in nerve does not contribute to the increase seen in myocardial cells when sympathetic ganglion cells and ventricular myocytes are grown in coculture. 30 Shah et a131 have shown previously that a pertussis toxin substrate links the a1-receptor to the Na-K pump, such that a1-receptor stimulation increases pump current, thereby reducing automaticity. Moreover, we have shown previously that complete functional inactivation of the 41-kDa pertussis toxin substrate is not required to modify the response to a1-adrenergic stimulation.5 Rather, all that is needed is reduction of the substrate below a critical level, the precise value of which has yet to be determined. The present study offers the following evidence for this statement: 1) Ventricles from NGF-, placebo-, and antiserum-treated animals manifest differences in the 41-kDa substrate, rather than a complete failure to demonstrate substrate in the antiserum-treated group. 2) Even in untreated animals, there are differences in substrate between the ventricles showing an increase and those showing a decrease in automaticity (see control experiments). 3) There is heterogeneity of the 41-kDa family of GTP regulatory proteins, and it is likely that only one is responsible for transducing the a1-adrenergic response. Identification of which member of the 41-kDa family of proteins is responsible awaits study with specific antibody techniques. We have not concerned ourselves here with developmental changes in the adenylate cyclase-cyclic AMP second messenger system because prior studies have suggested that this does not link importantly or at all to a-adrenergic receptor-effector coupling via the 41-kDa pertussis toxin substrate.4 Furthermore, the mechanism responsible for the a1-adrenergic increase in autornaticity in the presence of low levels of the 41-kDa substrate has not yet been determined. It has been suggested that this mechanism may relate to stimulation of phosphatidylinositol metabolism. 32 Changes in Heart Rate and QT Interval In the rat, a gradual increase in sinus rate takes place from birth through about the fourth week of life, followed by a gradual decrease to the adult heart rate.20 This time course was seen in our study groups, although the NGF-treated rats had the fastest heart rates at both 10 days and 3 weeks. Hypertensive rats of the SHR type, in which sympathetic hyperactivity is present, have a faster heart rate compared with their normotensive controls, and the difference appears as early as the eighth day of life. 21 The fast heart rate observed in NGFtreated rats may similarly have been related to greater sympathetic innervation, which then persisted after NGF treatment had been stopped for 10 days (as suggested in Table 1 ).
In measuring the QT interval, we were considering another variable that is modulated by adrenergic stimulation. Certainly, both a-and 18-adrenergic agonists may modify repolarization, as has been shown in isolated tissues of several species.1,33 Moreover, abnormalities of innervation have been shown to alter the QT interval,34 which might result from delayed and/or asynchronous repolarization. Much has been written about "imbalances" of innervation between the right and left sympathetic chains and their ability to pathologically prolong the QT interval.6,7 Although an abnormal pattern of innervation was seen in the NGF antiserum group, we would stress that this is abnormal in that systemic administration of an antibody interfered with cardiac sympathetic neural growth. There appears to be no analogy to an imbalance of innervation resulting from failure of development or unilateral ablation of a portion of the sympathetic nervous system. We would also stress that the pattern of innervation seen in the antiserumtreated animals is more complex than the mere persistence of an immature type of innervation. Despite the fact that the physiological expression of a-adrenergic responsiveness is not unlike that of the normal immature heart, the increased but diffuse immunocytochemical staining for tyrosine hydroxylase, the near absence of tissue norepinephrine stores, and the high dopamine levels are not representative of immature yet normal tissue but, rather, are consistent with a pathological malfunction.
In that subset of animals in which we discontinued administration of NGF antibody on day 10, the QT interval had normalized by 3 weeks of age. Hence, the prolongation of the QT interval was transient and temporally associated with a change in the development of cardiac sympathetic nerves. Interestingly, an abnormal prolongation of the QT interval in the first days of life, often followed by a normalization in subsequent ECGs, has been found in some children diagnosed as having sudden infant death syndrome. 35 To allow any pathophysiological and clinical inferences, more data are needed relating the findings on the surface ECG to transmembrane potential characteristics of the heart and the likelihood of arrhythmogenesis. However, our data indicate that even a transient derangement in the course of cardiac sympathetic innervation, such as we induced in neonatal rats, can be associated with QT interval prolongation. Of equal importance, these data show that in this setting QT interval prolongation is accompanied not only by important electrophysiological changes but by anatomic and biochemical abnormalities as well. These findings might relate to arrhythmogenesis as follows: in ventricles with reduced sympathetic innervation, adrenergic stimulation can induce an increase in ventricular automaticity due to activation of both a1-adrenergic36 and /3-adrenergic receptor mechanisms. This event is at variance with the mature ventricular chronotropic response to al-receptor stimulation, which is a decrease in automaticity.3637 This suggests that, just as an a1-adrenergic-mediated mechanism may contribute to the rhythmic disturbances observed during experimental acute myocardial ischemia and reperfusion,3839 it may also have a role in dysrhythmias associated with abnormal innervation. The alteration in automaticity would then be conceived of as capable of initiating a premature beat or tachyarrhythmia. The alteration in repolarization, resulting in a long QT interval, is consistent with the hypothesis that such prolongation, perhaps associated with dispersion of repolarization, might predispose to abnormal conduction and reentry. 40 
